Navigation Links
H1 Pipeline on Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) for 2017 Market Therapeutics Growth and Assessment at ReportsnReports.com
Date:4/14/2017

PUNE, India, April 14, 2017 /PRNewswire/ --

The latest disease pipeline guide Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Pipeline Review, H1 2017, provides an overview of the Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) (Oncology) pipeline landscape. Past infection with the Epstein-Barr virus (EBV) and HIV infection are at increased risk compared to the general population. Treatment includes surgery, radiation therapy and chemotherapy.

Browse 66 Tables and 11 Figures, 44 Company Profiles, spread across 418 pages available at http://www.reportsnreports.com/reports/944607-hodgkin-lymphoma-b-cell-hodgkin-lymphoma-pipeline-review-h1-2017.html.

Companies Profiled are 4SC AG, AbbVie Inc, Actinium Pharmaceuticals Inc, ADC Therapeutics Sarl, Affimed GmbH, Alfa Wassermann SpA, Alissa Pharma, Amgen Inc, Arno Therapeutics Inc, Bristol-Myers Squibb Company, Celgene Corp, Cell Medica Ltd, Cellectis SA, Celleron Therapeutics Ltd, Cellular Biomedicine Group Inc, Constellation Pharmaceuticals Inc, Cornerstone Pharmaceuticals Inc, Curis Inc, Faron Pharmaceuticals Oy, Incyte Corp, Kite Pharma Inc, MedImmune LLC, Merck & Co Inc, Merck KGaA, Mesoblast Ltd, Millennium Pharmaceuticals Inc, Mirati Therapeutics Inc, Molecular Templates Inc, NantKwest Inc, NBE-Therapeutics AG, Pfizer Inc, Philogen SpA, Regeneron Pharmaceuticals Inc, Rhizen Pharmaceuticals SA, Rich Pharmaceuticals Inc, Seattle Genetics Inc, Selvita SA, Spectrum Pharmaceuticals Inc, Stemline Therapeutics Inc, Syndax Pharmaceuticals Inc, Taiwan Liposome Company Ltd, Theravectys SA, TRACON Pharmaceuticals Inc and Trillium Therapeutics Inc.

The Pharmaceutical and Healthcare latest pipeline guide Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Order a Copy of Report at http://www.reportsnreports.com/purchase.aspx?name=944607.

The Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 3, 25, 27, 1, 7 and 1 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 6, 5, 1 and 1 molecules, respectively.

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Reasons to Buy:

The report procures strategically important competitor information, analysis, and insights to formulate effective R&D strategies. Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. Find and recognize significant and varied types of therapeutics under development for Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) (Oncology). Classify potential new clients or partners in the target demographic.

Develop tactical initiatives by understanding the focus areas of leading companies. Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics. Formulate corrective measures for pipeline projects by understanding Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) (Oncology) pipeline depth and focus of Indication therapeutics. Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope. Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Other Related Reports

B-Cell Chronic Lymphocytic Leukaemia - Pipeline Review, H1 2017

Non-Hodgkin Lymphoma - Heat Map and Analysis

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H2 2016

Explore more reports on Pharmaceuticals market at http://www.reportsnreports.com/market-research/pharmaceuticals/.

About Us: 

ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.


Contact:
Ritesh Tiwari
2nd Floor, Metropole Building,
Next to Inox Theatre,
Bund Garden Road, Pune - 411001.
Maharashtra, India.
+ 1 888 391 5441
sales@reportsandreports.com

Connect with Us:

LinkedIn: http://www.linkedin.com/company/reportsnreports

RSS/Feeds: http://www.reportsnreports.com/feed/l-latestreports.xml



'/>"/>
SOURCE ReportsnReports
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Compression Therapy Market Pipeline 2017 Assessment Report by Companies and Product Overview Available at ReportsnReports.com
2. Cardiovascular Disorders Drug Development Pipeline Review 2017: 1,200 Pipeline Products within the CVD Therapy Area - Research and Markets
3. Antibacterial Therapies Drug Development Pipeline Review 2017: 1400 Products in Active Development - Which Companies are the Most Active? - Research and Markets
4. Orthopedic Bone Cement - Medical Devices Pipeline Assessment, 2017
5. Malignant Pleural Effusion - Pipeline Review, H1 2017
6. Merrimack Launches as New, Refocused Research & Clinical Development Company with Resources to Advance Prioritized Lead Pipeline Candidates MM-121, MM-141 and MM-310
7. QIAGEN Expands Liquid Biopsy Pipeline with AR-V7 Test in Prostate Cancer
8. Global Idiopathic Pulmonary Fibrosis (IPF) Pipeline Analysis 2016-2017: IPF Pipeline is Very Strong with a Total of 97 Drug Candidates - Research and Markets
9. Primary Hyperoxaluria - Pipeline Review, H1 2017
10. BioLineRx Announces Acquisition of Agalimmune Ltd. to Accelerate Expansion of Immuno-Oncology Pipeline
11. Global Immune Check Point Inhibitors Market & Clinical Pipeline Insight 2022 - Immunotherapy Represents a Paradigm Shift in Cancer Therapy Along Multiple Fronts - Research and Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2021)... ... March 29, 2021 , ... The University of Texas Health Science Center ... San Antonio Multispecialty and Research Hospital, a destination center for research and treatment of ... In a nod to the COVID-19 pandemic, the ceremony was held virtually. , William ...
(Date:3/30/2021)... ... March 29, 2021 , ... Iora Health ... primary care, has partnered with Devoted Health , one of the fastest-growing ... across Maricopa County and provides seniors with the highest-quality care and experience possible, ...
(Date:3/30/2021)... CITY (PRWEB) , ... March 29, 2021 , ... ... has joined the Vaccine Credential Initiative (VCI), a group bringing together leading health ... record of vaccination status, based on open, interoperable standards. By joining the VCI ...
Breaking Medicine Technology:
(Date:3/30/2021)... , ... March 29, 2021 , ... ... the 21st Century , A Virtual Workshop Presented by WCG FDAnews and Cerulean ... 4:30 pm EDT, https://wcg.swoogo.com/modern-sop-and-quality-systems , Are one’s SOPs written for the ...
(Date:3/30/2021)... ... March 29, 2021 , ... According to data released ... reproductive age (13-44) in need of publicly funded contraception live in counties impacted by ... Colorado’s 64 counties have lost some of their Title X resources. , The ...
(Date:3/30/2021)... ... March 29, 2021 , ... Health Literacy Innovations (HLI), a ... confusion due to low health literacy today announces a new partnership with the ... work with ACAP’s member Safety Net Health Plans, those that provide comprehensive health ...
(Date:3/30/2021)... ... ... Dr. Colin Campbell is proud to announce the 1 year anniversary in their new state ... internal medicine and is a primary care specialist who has been practicing for 23 years. ... keep South Jersey healthy one patient at a time. , “Over the past year, Dr. ...
(Date:3/30/2021)... ... March 30, 2021 , ... The COVID-19 ... and survivors; their families; and their caregivers. Crossroads4Hope is addressing the needs of ... emotional support system, MyGo2Support, which meets needs of people impacted by cancer, no ...
Breaking Medicine News(10 mins):